RUSSIAN VACCINE CLINICAL TRIALS RESULTS SHOW HUMAN ADENOVIRAL VECTORS MAY BE BETTER OPTION THAN VACCINES USING MRNK, CHIMPANZEE ADENOVIRUS – RDIF
RUSSIAN VACCINE CLINICAL TRIALS RESULTS SHOW HUMAN ADENOVIRAL VECTORS MAY BE BETTER OPTION THAN VACCINES USING MRNK, CHIMPANZEE ADENOVIRUS – RDIF.
